Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

VAV Lifesciences inks deal to supply synthetic phospholipids for m-RNA based COVID-19 vaccines

expresspharmaApril 21, 2021

Tag: VAV Lifesciences , LNP , VAV Lipids

PharmaSources Customer Service